Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 37
Filter
1.
Ecological Indicators ; 146:109920, 2023.
Article in English | ScienceDirect | ID: covidwho-2178154

ABSTRACT

To continue directing global sustainable development efforts from 2015 to 2030, the United Nations adopted 17 global development goals known as the Sustainable Development Goals (SDGs) when the Millennium Development Goals (MDGs) from 2000 to 2015 expired. Sustainable development of World Natural Heritage Sites is one of these 17 MDGs and a crucial step toward achieving global sustainability. A scientific and systematic indicator system that can measure the sustainable development of natural World Heritage Sites more objectively and fairly is urgently needed to support the establishment of SDG11.4 on a Chinese scale and to help with the subsequent promotion of the development of natural World Heritage Sites. This study proposes a comprehensive assessment indicator system for the sustainable development of natural heritage sites based on the theoretical framework of "value contribution-environmental effect” to quantify the sustainable development of natural heritage sites. The study is based on the ecological environment and regional economic and social data of Jiuzhaigou World Natural Heritage Site from 2010 to 2020. Finally, the degree of coupling and coordination between the natural environment and economic development is assessed and studied. The results show that tourism to the World Heritage Site drove rapid economic development in Jiuzhaigou County between 2010 and 2020. As the fame of the World Heritage Site Jiuzhaigou has grown, so has the per capita income of local locals, making them unduly reliant on tourists for a living. Meanwhile, both the 2017 earthquake and the COVID-19 epidemic in 2019 have had substantial detrimental effects on the local economy. Furthermore, the Jiuzhaigou sustainable development trend from 2010 to 2020 exhibits a "W-shaped” curve, and there is a high level of positive coupling between the Jiuzhaigou sustainable development trend and economic development, and the two are mutually reinforcing.

2.
Clinical Microbiology and Infection ; 2022.
Article in English | ScienceDirect | ID: covidwho-2149568

ABSTRACT

Background Solid organ transplant (SOT) recipients have increased morbidity and mortality risk from coronavirus disease 2019 (COVID-19). Objectives This study aimed to evaluate the immunogenicity of COVID-19 vaccines in SOT recipients. Data sources Electronic databases were searched for eligible reports published from December 1, 2019 to May 31, 2022. Study eligibility criteria We included reports evaluating the humoral immune response (HIR) or cellular immune response (CIR) rate in SOT recipients after COVID-19 vaccines. Participants SOT recipients who received COVID-19 vaccines. Assessment of risk of bias We used the Newcastle-Ottawa Scale to assess bias in case-control and cohort studies. For the randomized controlled trials, the Jadad Scale was used. Methods of data synthesis We used a random-effects model to calculate the pooled rates of immune response with 95% confidence intervals (CI). We used a risk ratio (RR) with 95% CI for a comparison of immune responses between SOT and healthy controls. Results A total of 91 reports involving 11,886 transplant recipients (lung: 655, heart: 539, liver: 1,946 and kidney: 8,746) and 2,125 healthy controls revealed pooled HIR rates after the 1st, 2nd, and 3rd COVID-19 vaccine doses in SOT recipients were 9.5% (95% CI: 7%-11.9%), 43.6% (95% CI: 39.3%-47.8%) and 55.1% (95% CI: 44.7%-65.6%), respectively. For specific organs, the HIR rates were still low after 1st dose vaccination (lung: 4.4%;kidney: 9.4%;heart: 13.2%;liver: 29.5%) and 2nd dose(lung: 28.4%;kidney: 37.6%;heart: 50.3%;liver: 64.5%). Conclusion A booster vaccination enhances the immunogenicity of COVID-19 vaccines in SOT, however, a significant share of the recipients still has not built a detectable HIR after the 3rd dose. This finding calls for alternative approaches, including the use of monoclonal antibodies. In addition, lung transplant recipients need urgent booster vaccination to improve the immune response.

3.
Frontiers in public health ; 10, 2022.
Article in English | EuropePMC | ID: covidwho-2126258

ABSTRACT

Aim COVID-19 patients' security is related to their mental health. However, the classification of this group's sense of security is still unclear. The aim of our research is to clarify the subtypes of security of patients infected with COVID-19, explore the factors affecting profile membership, and examine the relationship between security and psychological capital for the purpose of providing a reference for improving patients' sense of security and mental health. Methods A total of 650 COVID-19 patients in a mobile cabin hospital were selected for a cross-sectional survey from April to May 2022. They completed online self-report questionnaires that included a demographic questionnaire, security scale, and psychological capital scale. Data analysis included latent profile analysis, variance analysis, the Chi-square test, multiple comparisons, multivariate logistical regression, and hierarchical regression analysis. Results Three latent profiles were identified—low security (Class 1), moderate security (Class 2), and high security (Class 3)—accounting for 12.00, 49.51, and 38.49% of the total surveyed patients, respectively. In terms of the score of security and its two dimensions, Class 3 was higher than Class 2, and Class 2 was higher than Class 1 (all P < 0.001). Patients with difficulty falling asleep, sleep quality as usual, and lower tenacity were more likely to be grouped into Class 1 rather than Class 3;Patients from families with a per capita monthly household income <3,000 and lower self-efficacy and hope were more likely to be grouped into Classes 1 and 2 than into Class 3. Psychological capital was an important predictor of security, which could independently explain 18.70% of the variation in the patients' security. Conclusions Security has different classification features among patients with COVID-19 infection in mobile cabin hospitals. The security of over half of the patients surveyed is at the lower or middle level, and psychological capital is an important predictor of the patients' security. Medical staff should actively pay attention to patients with low security and help them to improve their security level and psychological capital.

4.
J Med Virol ; : e28256, 2022 Oct 28.
Article in English | MEDLINE | ID: covidwho-2094205

ABSTRACT

We aimed to investigate the hesitancy and willingness of parents to vaccinate themselves and their children with a booster dose against severe acute respiratory syndrome coronavirus 2 and related factors. We conducted a cross-sectional study in Puyang city, China. The information was collected, including demographic characteristics, willingness to receive a booster dose of coronavirus disease 2019 (COVID-19) vaccine, and attitudes and concerns toward COVID-19 and vaccines. Vaccine hesitancy was assessed in individuals completing the first two doses and booster eligible, while vaccine willingness was assessed in those completing the first two doses and not yet booster eligible. Among the participants completing two primary doses while not meeting the booster criteria, 95.4% (1465/1536) and 95.0% (1385/1458) had a willingness to a booster dose of COVID-19 vaccine for themselves and their children, respectively. Among the participants who met the booster criteria, 40.3% had vaccine hesitancy. Vaccine hesitancy and unwillingness tended to occur in people who were younger, less educated, less healthy, and with unsureness of vaccines' efficacy and adverse events (AE). The younger age of children, children in poorer health, and concern about the efficacy and AE of vaccines contributed to the participants' unwillingness to vaccinate their children. We observed a high willingness to the booster dose of COVID-19 vaccine both for the parents and their children, regardless of the eligibility to a booster dose. However, 40% of people had delayed vaccination behaviors. The promotion of scientific knowledge of vaccines' effectiveness and safety is needed, especially for people in poor health and parents with young children. Timely disclosure of AE caused by COVID-19 vaccines and proper aiding offered to people encountering AE are suggested.

5.
International Journal of Stress Management ; 2022.
Article in English | Web of Science | ID: covidwho-2069865

ABSTRACT

Critical incidents, defined as traumatic time-limited events, often happen unexpectedly, and have largely impacted employees in many ways. In this study, we apply the conservation of resources theory as our overarching framework to examine whether and when employees involved in a critical work incident would experience helplessness at work, which may consequently spill over into the life domain and negatively impact their well-being. Taking the COVID-19 as a typical example of critical incidents, we collected multiwave data from 765 Chinese doctors. The results showed that perceived COVID-19 event strength is positively related to doctors' helplessness at work, which further negatively impacts their presence of meaning in life. Besides, meaningful work exacerbates the effect of perceived COVID-19 event strength on doctors' helplessness, while social support and psychological detachment reduce the negative impact of helplessness on their presence of meaning in life. Our study calls attention to protection of the mental health and psychological well-being of employees faced with critical incidents at work and their psychological recovery, and sheds light on the effectiveness of social support and psychological detachment as resource replenishing mechanisms, while cautions against further emphasizing work meaningfulness to employees confronted with a highly novel, disruptive, and critical work event.

6.
Front Immunol ; 13: 994173, 2022.
Article in English | MEDLINE | ID: covidwho-2022760

ABSTRACT

Individuals infected with the human immunodeficiency virus type 1 (HIV-1) belong to the group of people most vulnerable to SARS-CoV-2 infections and the associated disease COVID-19. Here we describe SARS-CoV-2-specific antibody and cellular immune responses in a small cohort of immunological non-responder HIV-1 patients (HIV-INRs) after receiving the COVID-19 mRNA-based BioNTech/Pfizer vaccine. Compared to the control group of vaccinated healthy individuals that all developed a virus-specific immune response, 5 of 10 vaccinated HIV-1 patients showed insufficient immune responses. The lack of response was not directly correlated with patients CD4 cell counts. Three of the five non-responders that agreed to receive a booster vaccination subsequently generated a virus-specific response. Thus, even HIV-INRs can be efficiently vaccinated against COVID-19 but may require a follow-up by virus-specific immune monitoring to guarantee clinical vaccine benefits.


Subject(s)
COVID-19 , HIV Infections , Viral Vaccines , Antibodies, Viral , COVID-19/prevention & control , COVID-19 Vaccines , Humans , Immunity , RNA, Messenger/genetics , SARS-CoV-2 , Vaccination
7.
Front Med (Lausanne) ; 9: 822796, 2022.
Article in English | MEDLINE | ID: covidwho-2009873

ABSTRACT

Background: The changing pattern of pathogen spectrum causing herpangina in the time of coronavirus disease 2019 (COVID-19) pandemic was unknown. The purpose of this study was to investigate the changes on the molecular epidemiology of herpangina children during 2019-2020 in Tongzhou district, Beijing, China. Method: From January 2019 to December 2020, children diagnosed with herpangina were recruited by the staff from Tongzhou Center for Disease Control and Prevention (CDC) in Beijing. Viral RNA extraction from pharyngeal swabs was used for enterovirus (EV) detection and the complete VP1 gene was sequenced. The phylogenetic analysis was performed based on all VP1 sequences for EV genotypes. Result: A total of 1,331 herpangina children were identified during 2019-2020 with 1,121 in 2019 and 210 in 2020, respectively. The predominant epidemic peak of herpangina children was in summer and autumn of 2019, but not observed in 2020. Compared to the number of herpangina children reported in 2019, it decreased sharply in 2020. Among 129 samples tested in 2019, 61 (47.3%) children were detected with EV, while 22.5% (20/89) were positive in 2020. The positive rate for EV increased since June 2019, peaked at August 2019, and decreased continuously until February 2020. No cases were observed from February to July in 2020, and the positive rate of EV rebounded to previous level since August 2020. Four genotypes, including coxsackievirus A6 (CV-A6, 9.3%), CV-A4 (7.8%), CV-A10 (2.3%) and CV-A16 (10.1%), were identified in 2019, and only three genotypes, including CV-A6 (9.0%), CV-A10 (6.7%) and CV-A16 (1.1%), were identified in 2020. The phylogenetic analysis showed that all CV-A6 strains from Tongzhou located in Group C, and the predominant strains mainly located in C2-C4 subgroups during 2016-2018 and changed into C1 subgroup during 2018-2020. CV-A16 strains mainly located in Group B, which consisting of strains widely distributed around the world. Conclusions: The predominant genotypes gradually shifted from CV-A16, CV-A4 and CV-A6 in 2019 to CV-A6 in 2020 under COVID-19 pandemic. Genotype-based surveillance will provide robust evidence and facilitate the development of public health measures.

8.
Liver Int ; 2022 Aug 20.
Article in English | MEDLINE | ID: covidwho-2001716

ABSTRACT

BACKGROUND AND AIMS: Chronic liver disease (CLD) patients and liver transplant (LT) recipients have an increased risk of morbidity and mortality from coronavirus disease 2019 (COVID-19). The immunogenicity of COVID-19 vaccines in CLD patients and LT recipients is poorly understood. The present study aimed to evaluate the immunogenicity of COVID-19 vaccines in CLD patients and LT recipients. METHODS: We searched electronic databases for eligible studies. Two reviewers independently conducted the literature search, extracted the data and assessed the risk of bias of included studies. The rates of detectable immune response were pooled from single-arm studies. For comparative studies, we compared the rates of detectable immune response between patients and healthy controls. The meta-analysis was conducted using the Stata software with a random-effects model. RESULTS: In total, 19 observational studies involving 4191 participants met the inclusion criteria. The pooled rates of detectable humoral immune response after two doses of COVID-19 vaccination in CLD patients and LT recipients were 95% (95% confidence interval [CI] = 88%-99%) and 66% (95% CI = 57%-74%) respectively. After two doses of vaccination, the humoral immune response rate was similar in CLD patients and healthy controls (risk ratio [RR] = 0.96; 95% CI = 0.90-1.02; p = .14). In contrast, LT recipients had a lower humoral immune response rate after two doses of vaccination than healthy controls (RR = 0.68; 95% CI = 0.59-0.77; p < .01). CONCLUSIONS: Our meta-analysis demonstrated that COVID-19 vaccination induced strong humoral immune responses in CLD patients but poor humoral immune responses in LT recipients.

9.
Kidney360 ; 3(6): 1047-1056, 2022 06 30.
Article in English | MEDLINE | ID: covidwho-1989003

ABSTRACT

Background: Recent investigations have shown that, on average, patients hospitalized with coronavirus disease 2019 (COVID-19) have a poorer postdischarge prognosis than those hospitalized without COVID-19, but this effect remains unclear among patients with end-stage kidney disease (ESKD) who are on dialysis. Methods: Leveraging a national ESKD patient claims database administered by the US Centers for Medicare and Medicaid Services, we conducted a retrospective cohort study that characterized the effects of in-hospital COVID-19 on all-cause unplanned readmission and death within 30 days of discharge for patients on dialysis. Included in this study were 436,745 live acute-care hospital discharges of 222,154 Medicare beneficiaries on dialysis from 7871 Medicare-certified dialysis facilities between January 1 and October 31, 2020. Adjusting for patient demographics, clinical characteristics, and prevalent comorbidities, we fit facility-stratified Cox cause-specific hazard models with two interval-specific (1-7 and 8-30 days after hospital discharge) effects of in-hospital COVID-19 and effects of prehospitalization COVID-19. Results: The hazard ratios due to in-hospital COVID-19 over the first 7 days after discharge were 95% CI, 1.53 to 1.65 for readmission and 95% CI, 1.38 to 1.70 for death, both with P<0.001. For the remaining 23 days, the hazard ratios were 95% CI, 0.89 to 0.96 and 95% CI, 0.86 to 1.07, with P<0.001 and P=0.50, respectively. Effects of prehospitalization COVID-19 were mostly nonsignificant. Conclusions: In-hospital COVID-19 had an adverse effect on both postdischarge readmission and death over the first week. With the surviving patients having COVID-19 substantially selected from those hospitalized, in-hospital COVID-19 was associated with lower rates of readmission and death starting from the second week.


Subject(s)
COVID-19 , Kidney Failure, Chronic , Aftercare , Aged , COVID-19/epidemiology , Humans , Kidney Failure, Chronic/epidemiology , Medicare , Patient Discharge , Renal Dialysis , Retrospective Studies , United States/epidemiology
10.
Sustainability ; 14(15):8985, 2022.
Article in English | MDPI | ID: covidwho-1957426

ABSTRACT

Managing climate change is synonymous to managing cities and their growth. To shoulder the challenge of climate change adaptation, informal settlement upgrading in the global south has amounted to the importance of being attuned with the growth of its city and region at large. Changing the paradigm of on-site upgrading to being community-driven and city-led with domestic funding unlocks potentials for community resilience building, especially in countries that strive for inclusive growth. This research looks into informal settlement development dynamics and its resilience stance in conjunction of the metropolitan growth in three Southeast Asian countries. Greater Manila Area, Bangkok Metropolitan Region and Hanoi Capital Region serve as the backdrop for this investigation. The research mainly addresses informal settlement upgrading roles, mechanism and approaches for resilience building in these three metropolises, meanwhile also unveiling their city-regional development needs. The methodological approach of this study is highly participatory, demonstrating a hybrid of multi-spectrum stakeholder workshops, online surveys (due to COVID), expert interviews, project interim reports and correspondence with the local expert team in the three countries, etc. The paper attempts at providing a cross-country appraisal of the central strategies of informal settlement upgrading, related institutional constellations and upgrading applications along with the three metropolises' urban development. This attempt accentuates the pressing needs of mitigating multi-facet vulnerability of informal communities, who are the most adversely affected by climate change and rampant urbanization. Further, this research will also reveal the mindset change of how decision-makers and the public contemplate upgrading objectives, e.g., recasting secure tenure instruments.

11.
Front Psychiatry ; 13: 882385, 2022.
Article in English | MEDLINE | ID: covidwho-1957198

ABSTRACT

Background: Nurses play an important role in medical and health services and insomnia symptoms were relatively high among nurses, especially during the epidemic of 2019 coronavirus disease. Insomnia not only damages the physical and mental health of the individual, but also reduces the efficiency of their work and the quality of care, ultimately impacting on patient care. Objective: The purpose of this study was to explore the role of perceived organizational support and psychological capital in the relationship between occupational stress and insomnia among Chinese nurses. Methods: A cross-sectional study has been carried out in a tertiary grade A hospital in Shandong Province, China from March 2021 to May 2021. The self-administered questionnaires were distributed to 810 nurses, which including Chinese Effort-Reward Imbalance Scale, Athens Insomnia Scale, Perceived Organizational Support Questionnaire, Chinese Psychological Capital Questionnaire, gender, age, education level and other demographic characteristics. Effective respondents were 658 (81.2%). Descriptive analysis, independent-samples t-test, one-way analysis of variance, Pearson correlation analyses, ordinary least-squares regression and the bootstrap method were used for data analysis. Results: The prevalence of insomnia symptoms in this study was found to be 57.3%. There were significant differences in insomnia symptoms in weekly working hours (t = -2.027, P = 0.043), with chronic disease (t = -2.825, P = 0.005), negative life events (t = -5.340, P < 0.001), departments (F = 3.077, P = 0.006) and position (t = 2.322, P = 0.021) among nurses. Overall, the serial-multiple mediations of perceived organizational support and psychological capital in the relationship between occupational stress and insomnia were found to be statistically significant. Conclusions: The prevalence of insomnia symptoms was comparatively high among Chinese nurses, and occupational stress had direct negative influence on it. Perceived organizational support and psychological capital acted as chained mediating factor could partially relieve insomnia symptoms related to occupational stress. Supportive working environment should be provided, and improving psychological capital levels to help nurses coping with insomnia symptoms.

12.
Front Med (Lausanne) ; 9: 924267, 2022.
Article in English | MEDLINE | ID: covidwho-1933710

ABSTRACT

Background: CD4/CD8 ratio has been used as a quantitative prognostic risk factor in patients with viral infections. This study aims to assess the association between in-hospital mortality and at admission CD4/CD8 ratio among individuals with acute SARS-CoV-2 infection. Methods: This is a longitudinal cohort study with data of all consecutive patients admitted to the COVID-19 unit at Hospital del Mar, Barcelona, Spain for ≥48 h between March to May 2020. The CD4+ CD8+ T-cell subset differentiation was assessed by flow cytometry at admission as well as a complete blood test. Patients were classified according to CD4/CD8 ratio tertiles. The primary outcome was in-hospital mortality and the secondary outcome was acute respiratory distress (ARDS). Results: A total of 338 patients were included in the cohort. A high CD4/CD8 ratio (third tertile) was associated with a higher in-hospital mortality [adjusted Cox model hazard ratio (HR) 4.68 (95%CI 1.56-14.04, p = 0.006), reference: second tertile HR 1]. Similarly, a high CD4/CD8 ratio (third tertile) was associated with a higher incidence of ARDS [adjusted logistic regression model OR 1.97 (95%CI 1.11-3.55, p = 0.022) reference: second tertile HR 1]. There was a trend of higher in-hospital mortality and incidence of ARDS in patients within the first tertile of CD4/CD8 ratio compared with the second one, but the difference was not significant. No associations were found with total lymphocyte count or inflammatory parameters, including D-dimer. Conclusion: CD4/CD8 ratio is a prognostic factor for the severity of COVID-19, reflecting the negative impact on prognosis of those individuals whose immune response has abnormal CD8+ T-cell expansion during the early response to the infection.

13.
PeerJ ; 10: e13608, 2022.
Article in English | MEDLINE | ID: covidwho-1912095

ABSTRACT

Background: Thrombocytopenia was common in the coronavirus disease 2019 (COVID-19) patients during the infection, while the role of thrombocytopenia in COVID-19 pathogenesis and its relationship with systemic host response remained obscure. The study aimed to systematically evaluate the relationship between thrombocytopenia in COVID-19 patients and clinical, haematological and biochemical markers of the disease as well as adverse outcomes. Methods: To assess the relationship between abnormal platelet levels and disease progression, a multi-center retrospective cohort study was conducted. COVID-19 patients with thrombocytopenia and a sub-cohort of matched patients without thrombocytopenia were compared for their clinical manifestations, haematological disorders, biochemical parameters, inflammatory markers and clinical outcome. Results: Thrombocytopenia was present in 127 of 2,209 analyzed patients on admission. Compared with the control group, thrombocytopenia patients developed significantly higher frequency of respiratory failure (41.9% vs. 22.6%, P = 0.020), intensive care unit entrance (25.6% vs. 11.5%, P = 0.012), disseminated intravascular coagulation (45.2% vs. 10.6%, P < 0.001), more altered platelet morphology indexes and coagulation perturbation, higher levels of inflammatory markers. In addition, a significantly increased all-cause mortality (hazard ratio 3.08, 95% confidence interval 2.26-4.18, P < 0.001) was also observed in the patients with thrombocytopenia. Late development of thrombocytopenia beyond 14 days post-symptom was observed in 61 patients, from whom a comparable mortality rate yet longer duration to death was observed compared to those with early thrombocytopenia. Conclusions: Our finding from this study adds to previous evidence that thrombocytopenia is associated with adverse outcome of the disease and recommend that platelet count and indices be included alongside other haematological, biochemical and inflammatory markers in COVID-19 patients' assessment during the hospital stay.

14.
J Med Virol ; 94(8): 3801-3810, 2022 08.
Article in English | MEDLINE | ID: covidwho-1888745

ABSTRACT

Influenza-like illness (ILI) varies in intensity year by year, generally keeping a stable pattern except for great changes of its epidemic pattern. Of the most impacting factors, urbanization has been suggested as shaping the intensity of influenza epidemics. Besides, growing evidence indicates the nonpharmaceutical interventions (NPIs) to severe acute respiratory syndrome coronavirus 2 offer great advantages in controlling infectious diseases. The present study aimed to evaluate the impact of urbanization and NPIs on the dynamic of ILI in Tongzhou, Beijing, during January 2013 to March 2021. ILI epidemiological surveillance data in Tongzhou district were obtained from Beijing Influenza Surveillance Network and separated into three periods of urbanization and four intervals of coronavirus disease 2019 pandemic. Standardized average incidence rates of ILI in each separate stages were calculated and compared by using Wilson method and time series model of seasonal ARIMA. Influenza seasonal outbreaks showed similar epidemic size and intensity before urbanization during 2013-2016. Increased ILI activity was found during the process of Tongzhou's urbanization during 2017-2019, with the rate difference of 2.48 (95% confidence interva [CI]: 2.44, 2.52) and the rate ratio of 1.75 (95% CI: 1.74, 1.76) of ILI incidence between preurbanization and urbanization periods. ILI activity abruptly decreased from the beginning of 2020 and kept at the bottom level almost in every epidemic interval. The top decrease in ILI activity by NPIs was shown in 5-14 years group in 2020-2021 influenza season, as 92.2% (95% CI: 78.3%, 95.2%). The results indicated that both urbanization and NPIs interrupted the epidemic pattern of ILI. We should pay more attention to public health when facing increasing population density, human contact, population mobility, and migration in the process of urbanization. NPIs and influenza vaccination should be implemented as necessary measures to protect people from common infectious diseases like ILI.


Subject(s)
COVID-19 , Influenza, Human , Virus Diseases , Beijing/epidemiology , COVID-19/epidemiology , COVID-19/prevention & control , Humans , Influenza, Human/epidemiology , Influenza, Human/prevention & control , Pandemics , Seasons , Urbanization , Virus Diseases/epidemiology
16.
Frontiers in medicine ; 9, 2022.
Article in English | EuropePMC | ID: covidwho-1824548

ABSTRACT

Background The changing pattern of pathogen spectrum causing herpangina in the time of coronavirus disease 2019 (COVID-19) pandemic was unknown. The purpose of this study was to investigate the changes on the molecular epidemiology of herpangina children during 2019-2020 in Tongzhou district, Beijing, China. Method From January 2019 to December 2020, children diagnosed with herpangina were recruited by the staff from Tongzhou Center for Disease Control and Prevention (CDC) in Beijing. Viral RNA extraction from pharyngeal swabs was used for enterovirus (EV) detection and the complete VP1 gene was sequenced. The phylogenetic analysis was performed based on all VP1 sequences for EV genotypes. Result A total of 1,331 herpangina children were identified during 2019-2020 with 1,121 in 2019 and 210 in 2020, respectively. The predominant epidemic peak of herpangina children was in summer and autumn of 2019, but not observed in 2020. Compared to the number of herpangina children reported in 2019, it decreased sharply in 2020. Among 129 samples tested in 2019, 61 (47.3%) children were detected with EV, while 22.5% (20/89) were positive in 2020. The positive rate for EV increased since June 2019, peaked at August 2019, and decreased continuously until February 2020. No cases were observed from February to July in 2020, and the positive rate of EV rebounded to previous level since August 2020. Four genotypes, including coxsackievirus A6 (CV-A6, 9.3%), CV-A4 (7.8%), CV-A10 (2.3%) and CV-A16 (10.1%), were identified in 2019, and only three genotypes, including CV-A6 (9.0%), CV-A10 (6.7%) and CV-A16 (1.1%), were identified in 2020. The phylogenetic analysis showed that all CV-A6 strains from Tongzhou located in Group C, and the predominant strains mainly located in C2-C4 subgroups during 2016-2018 and changed into C1 subgroup during 2018-2020. CV-A16 strains mainly located in Group B, which consisting of strains widely distributed around the world. Conclusions The predominant genotypes gradually shifted from CV-A16, CV-A4 and CV-A6 in 2019 to CV-A6 in 2020 under COVID-19 pandemic. Genotype-based surveillance will provide robust evidence and facilitate the development of public health measures.

17.
Sci Rep ; 12(1): 6929, 2022 04 28.
Article in English | MEDLINE | ID: covidwho-1815599

ABSTRACT

One of the hallmarks of SARS-CoV-2 infection is an induced immune dysregulation, in some cases resulting in cytokine storm syndrome and acute respiratory distress syndrome (ARDS). Several physiological parameters are altered as a result of infection and cytokine storm. Among them, microRNAs (miRNAs) might reflect this poor condition since they play a significant role in immune cellular performance including inflammatory responses. Circulating miRNAs in patients who underwent ARDS and needed mechanical ventilation (MV+; n = 15) were analyzed by next generation sequencing in comparison with patients who had COVID-19 poor symptoms but without intensive care unit requirement (MV-; n = 13). A comprehensive in silico analysis by integration with public gene expression dataset and pathway enrichment was performed. Whole miRNA sequencing identified 170 differentially expressed miRNAs between patient groups. After the validation step by qPCR in an independent sample set (MV+ = 10 vs. MV- = 10), the miR-369-3p was found significantly decreased in MV+ patients (Fold change - 2.7). After integrating with gene expression results from COVID-19 patients, the most significant GO enriched pathways were acute inflammatory response, regulation of transmembrane receptor protein Ser/Thr, fat cell differentiation, and regulation of biomineralization and ossification. In conclusion, miR-369-3p was altered in patients with mechanical ventilation requirement in comparison with COVID-19 patients without this requirement. This miRNA is involved in inflammatory response which it can be considered as a prognosis factor for ARDS in COVID-19 patients.


Subject(s)
COVID-19 , Circulating MicroRNA , MicroRNAs , Respiratory Distress Syndrome , COVID-19/complications , COVID-19/genetics , Circulating MicroRNA/genetics , Cytokine Release Syndrome , Humans , MicroRNAs/genetics , Respiratory Distress Syndrome/genetics , SARS-CoV-2
18.
Procedia Comput Sci ; 200: 451-460, 2022.
Article in English | MEDLINE | ID: covidwho-1796206

ABSTRACT

The COVID-19 pandemic has forced a sudden change of traditional office works to smart working models, which however force many workers staying at home with a significant increase of sedentary lifestyle. Metabolic disorders, mental illnesses, and musculoskeletal injuries are also caused by the physical inactivity and chronic stress at work, threatening office workers' physical and physiological health. In the modern vision of smart workplaces, cyber-physical systems play a central role to augment objects, environments, and workers with integrated sensing, data processing, and communication capabilities. In this context, a work engagement system is proposed to monitor psycho-physical comfort and provide health suggestion to the office workers. Recognizing their activity, such as sitting postures and facial expressions, could help assessing the level of work engagement. In particular, head and body posture could reflects their state of engagement, boredom or neutral condition. In this paper we proposed a method to recognize such activities using an infrared sensor array by analyzing the sitting postures. The proposed approach can unobstructively sense their activities in a privacy-preserving way. To evaluate the performance of the system, a working scenario has been set up, and their activities were annotated by reviewing the video of the subjects. We carried out an experimental analysis and compared Decision Tree and k-NN classifiers, both of them showed high recognition rate for the eight postures. As to the work engagement assessment, we analyzed the sitting postures to give the users suggestions to take a break when the postures such as lean left/right with arm support, lean left/right without arm support happens very often.

19.
Frontiers in immunology ; 13, 2022.
Article in English | EuropePMC | ID: covidwho-1762622

ABSTRACT

Abnormal function of immune cells is one of the key mechanisms leading to severe clinical symptoms in coronavirus disease 2019 patients, and metabolic pathways can destroy the function of the immune system by affecting innate and adaptive immune responses. However, the metabolic characteristics of the immune cells of the SARS-CoV-2 infected organs in situ remaining elusive. We reanalyzed the metabolic-related gene profiles in single-cell RNA sequencing data, drew the metabolic landscape in bronchoalveolar lavage fluid immune cells, and elucidated the metabolic remodeling mechanism that might lead to the progression of COVID-19 and the cytokine storm. Enhanced glycolysis is the most important common metabolic feature of all immune cells in COVID-19 patients. CCL2+ T cells, Group 2 macrophages with high SPP1 expression and myeloid dendritic cells are among the main contributors to the cytokine storm produced by infected lung tissue. Two metabolic analysis methods, including Compass, showed that glycolysis, fatty acid metabolism, bile acid synthesis and purine and pyrimidine metabolism levels of CCL2+ T cells, Group 2 macrophages and myeloid dendritic cells were upregulated and correlated with cytokine storms of COVID-19 patients. This might be the key metabolic regulatory factor for immune cells to produce large quantities of cytokines.

SELECTION OF CITATIONS
SEARCH DETAIL